ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,799.34
      -0.17%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lyell Immunopharma Inc (LYEL)

      7. Lyell Immunopharma Inc (LYEL) Financials

      Lyell Immunopharma Inc

      Lyell Immunopharma Inc (LYEL)

      NASDAQ
      1.64
      0.01
      (0.61%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      1.64
      0.00
      (0.00%)
      After Hours: 5:59PM
      Delayed by 15 minutes

      Lyell Immunopharma Inc Financial Summary

      The current LYEL market cap is 418.1M. The company's latest EPS is USD -0.9203 and P/E is -1.78.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.35M596k317k654k1.09M
      Operating Income -62.56M-65.91M-59.04M-59.51M-55.58M
      Net Income -66.96M-63.89M-50.85M-52.93M-60.67M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 657k17.19M12.97M89.44M2.92M
      Operating Income -102.09M-211.94M-214.78M-187.06M-247.01M
      Net Income -129.38M-204.47M-250.22M-183.12M-234.63M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 880.45M835.35M794.99M750.03M694.22M
      Total Liabilities 96.62M98.5M97.42M95.08M91.06M
      Total Equity 783.83M736.86M697.57M654.95M603.16M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 555.63M908.28M1.13B937.56M750.03M
      Total Liabilities 147.58M189.84M197.62M104.31M95.08M
      Total Equity -111.11M-292.53M929.79M833.25M654.95M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -46.21M-85.37M-123.06M-163.69M-42.02M
      Investing 32.15M185.07M284.74M184.05M21.99M
      Financing -69k1.13M984k1.74M27k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 39.47M-160.87M-126.25M-169.56M-163.69M
      Investing -422.43M-273.52M-121.57M-11.54M184.05M
      Financing 351.16M476.79M401.24M10.64M1.74M

      Stats and Ratios

      Market Cap 418.1M
      Price to Earnings Ratio -1.78
      Price to Sales Ratio 142.61
      Price to Cash Ratio 2.87
      Price to Book Ratio 0.64
      Dividend Yield -

      Share Statistics

      Shares Outstanding 254.94M
      Average Volume (1 week) 526.97k
      Average Volume (1 Month) 721.86k
      52 Week Change -44.97%
      52 Week High 3.2556
      52 Week Low 1.18
      Spread (Intraday) 0.19 (10.98%)

      Company Info

      Company Name Lyell Immunopharma Inc
      Address 3500 s dupont hwy
      dover, delaware 19901
      Website https://lyell.com
      Industry pharmaceutical preparations (2834)